Get Premium Data for Cyber Monday: Up to 55% Off InvestingProCLAIM SALE

Waters Corporation (WAT)

NYSE
Currency in USD
384.05
+2.72(+0.71%)
Closed
After Hours
384.050.00(0.00%)
WAT Scorecard
Full Analysis
13 analysts have revised their earnings downwards for the upcoming period
Fair Value
Day's Range
380.60386.76
52 wk Range
279.24395.50
Key Statistics
Edit
Prev. Close
381.33
Open
383.95
Day's Range
380.6-386.76
52 wk Range
279.24-395.5
Volume
416.76K
Average Volume (3m)
471.4K
1-Year Change
30.91%
Book Value / Share
unlockUnlock
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
WAT Scorecardpro icon
Company’s Health
pro lockUnlock
Fair Value
pro lockUnlock Price
Fair Pricepro lock
Upsidepro lock
Price Target
376.04
Downside
-2.09%
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high earnings multiple
Show more

Waters Company Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.

Waters Corporation SWOT Analysis


Market Challenges
Waters Corporation faces headwinds in Industrial and Applied & General segments, with significant declines in quarterly instrument revenues impacting overall performance.
Pharma Sector Strength
Explore Waters' robust position in the Pharmaceutical segment, offering potential for growth and stability amidst broader market uncertainties.
Recovery Prospects
Delve into management's optimistic outlook for a strong second-half recovery, particularly in Q4, despite conservative guidance and market skepticism.
Analyst Perspectives
Barclays Capital sets price targets of $295-$300, reflecting cautious optimism amid Waters' efforts to navigate challenging market conditions.
Read full SWOT analysis
WAT Full Pro Research
Institutional-Grade Stock Analysis
Understand how WAT earns money
Financial health at a glance
Bearish and bullish outlooks
Latest expert insights
Actionable Pro Tips, and many more...
Gain access to 1400+ in-depth research reports on the most popular US stocks

Waters Corporation Earnings Call Summary for Q4/2024

  • Q3 revenue up 4% YoY to $740M; non-GAAP EPS at $2.93, up 3% YoY
  • LC segment returns to growth; Xevo TQ Absolute mass spectrometer sales surge over 70%
  • Full-year 2024 organic constant currency sales growth guidance updated to -0.9% to -0.3%
  • Q4 2024 growth projected at 5-7%; focus on bioseparations and new testing capacity
  • China sales declined 5% due to shipment delays; conservative outlook for 2024
Last Updated: 01-11-2024, 11:42 pm
Read Full Transcript

Compare WAT to Peers and Sector

Metrics to compare
WAT
Peers
Sector
Relationship
P/E Ratio
36.6x26.2x−0.6x
PEG Ratio
−7.730.100.00
Price/Book
14.2x4.1x2.6x
Price / LTM Sales
7.8x2.4x3.2x
Upside (Analyst Target)
−3.5%25.9%44.6%
Fair Value Upside
Unlock−0.9%7.3%Unlock

Analysts' Recommendations

3 Buy
15 Hold
2 Sell
Ratings:
17 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 376.04

(-2.09% Downside)

FAQ

What Is the Waters (WAT) Stock Price Today?

The Waters stock price today is 384.05.

What Stock Exchange Does Waters Trade On?

Waters is listed and trades on the NYSE stock exchange.

What Is the Stock Symbol for Waters?

The stock symbol for Waters is "WAT."

What Is the Waters Market Cap?

As of today, Waters market cap is 22.80B.

What is Waters Earnings Per Share?

The Waters EPS is 10.51.

What Is the Next Waters Earnings Date?

Waters will release its next earnings report on 10 Feb 2025.

From a Technical Analysis Perspective, Is WAT a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.